AMCP has released Version 4.1 of the AMCP Format for Formulary Submissions, which includes two new dossier types for biopharmaceutical manufacturers to share evidence on unapproved products and new indications that are under review by the U.S. Food and Drug Administration (FDA).

AMCP webinar that provided insights around the evolution of the pre-approval information exchange between manufacturers and payers.

AMCP webinar that reviewed the current pre-approval support features within FormuarlyDecisions.com and insights from the active FormularyDecisions.com Payer community.

AMCP webinar that discussed the current state of payer perceptions regarding dossier timing, quality and use as well as future considerations for improving dossier relevancy and optimization of use.

AMCP webinar that discussed the significance of the shifting landscape and the dilemmas of the FDA accelerated approval process.

Press Release: "Precision medicine is no longer emerging, it's happening now," according to Susan A. Cantrell, RPh, CAE, CEO of the Academy of Managed Care Pharmacy (AMCP).

Partnership Forum: Industry leaders gather together on September 13-14, 2016 to develope recommendations for biopharmaceutical companies and health care decision makers to more easily communicate information on products awaiting FDA approval.